Key facts
- It has raised $24.0M; the latest was Later Stage VC in May 2025.
- Notable investors include Ningbo Qianwan Venture Capital, Chengshu Capital, GP Capital (Shanghai), Haichuang Group, Shenzhen HTI Group.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for HICREN Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for HICREN Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HICREN Biotech
Manufacturer of curved vertebroplasty products designed for orthopedic surgery. The company manufactures bone repair materials, sports medicine products, interspine implants, and endoscopy devices, providing doctors with robot-enabled orthopedic minimally invasive devices.
- Sector
- Healthcare
- HQ
- Ningbo, China
- Founded
- 2011
- Employees
- 111
- Website
- hicren.com.cn/
- Ownership
- Privately Held (backing)
HICREN Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HICREN Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HICREN Biotech in its N-PORT filings yet. We sweep new filings monthly.